Oct 30 2009
OrthoAccel Technologies, Inc., developers of the AcceleDent System, which is an acceleration device for orthodontics, has just completed the sale of the product to several key opinion leaders in the United Kingdom. Doctors Gerry Bellman, Angelos Alvanos, and Asif Chatoo are in private practice in the London area while Dr. Lars Christensen is in private practice in Oxford.
AcceleDent is a simple, removable dental device that patients wear in the mouth for twenty minutes daily. It generates a light microvibration force which modulates the bone tissue remodeling process and accelerates orthodontic tooth movement. The device is hands-free and allows the user flexibility to carry out most routine tasks during the twenty-minute use session.
Dr. Bellman, an orthodontic specialist, is the first to treat a patient outside of the USA where the Company has been conducting human clinical trials. The patient is a 28-year old female initially being treated with a fixed orthodontic appliance, with a treatment plan to later include a clear aligner (Invisalign). The doctor and patient were very excited by how easy the AcceleDent System is to use and look forward to a significantly reduced treatment time. Dr. Bellman commented, "I was very excited to fit the first AcceleDent appliance to a patient in the UK. It was extremely easy to fit and my patient found it very simple to position in her mouth and use. I look forward to monitoring the accelerated movement of her teeth over the coming months."
Results from the initial clinical trial demonstrated an overall tooth movement rate of 2.1 mm per month, which is 30% to 50% faster than what is reported in the literature. This same study further demonstrated the safety of the AcceleDent System through a detailed measurement and statistical analysis of root resorption yielding mean values below 0.5 mm. It should be noted that 0.5 mm is well below the levels of 2 mm, or one-third of the root length, considered clinically significant by researchers.
Source:
OrthoAccel Technologies, Inc.